IL1B and cancer: When we inhibited miR-146a and miR-181b with anti-miRs, we observed that the TEM of both HT29 and LoVo cancer cells was increased by about two-fold (Fig. 4A,B, left panels; Supplementary Figs S3,S4) in the presence of IL-1β.